NCT00003406View on ClinicalTrials.gov

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 1997

Study Completion Date

March 31, 2000

Conditions

Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous/Nonmalignant ConditionUnspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

carboplatin

DRUG

docetaxel

DRUG

ifosfamide

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

60099

Midwestern Regional Medical Center, Zion

All Listed Sponsors

lead

Cancer Treatment Centers of America

OTHER

NCT00003406 - Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer | Biotech Hunter | Biotech Hunter